A2DMQY Cronos Group Inc

Cronos Unveils its New THCV Products: Spinach FEELZ™ Full Tilt

Cronos Unveils its New THCV Products: Spinach FEELZ™ Full Tilt

TORONTO, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabinoid company, announced the launch of two new THCV-infused products; Spinach FEELZ™ Full Tilt THCV vape and gummy. Cronos also plans to launch a THCV-infused pre-roll under the Spinach FEELZ™ brand, which will add an additional offering under its robust and growing pre-roll portfolio.

The Full Tilt THCV lineup is designed to give adult consumers an exciting new cannabis experience. The Spinach FEELZ™ Full Tilt product range includes:

  • Spinach FEELZFull Tilt Blue Razz Durban 7:1 THC|THCV vape
    • 700mg of THC and 100mg of THCV per 1g cartridge
  • Spinach FEELZFull Tilt Blue Raspberry Lemonade 1:2 THC|THCV gummies
    • 5 pieces/pack with 10mg of THC and 20mg THCV per pack

The THCV vape is now available in Alberta, British Columbia, and Ontario and the THCV edibles are available now in Ontario and British Columbia and will be available in Alberta by November 30. THCV infused pre-rolls are planned for launch in 2024.

“We’re incredibly excited about the possibilities of THCV and these new products under the Spinach FEELZ™ Full Tilt lineup do not disappoint,” said Mike Gorenstein, Chairman, President, and CEO, Cronos. “Full Tilt features the perfect products to boost your high, when you’re looking to get more of what you want out of your favorite THC experiences. Our expertly-crafted formulation offers its own unique and differentiated experience, perfect for when you’re in the mood to turn the world on its head and see where you end up.”

Through Spinach FEELZ™, Cronos is committed to bringing a full line of products featuring rare cannabinoids to consumers in a wide range of product formats. Each product is designed to deliver unique and enhanced experiences made possible through proprietary blends of rare cannabinoids alongside more well-known cannabinoids, like THC and CBD. Each product is formulated to help adult consumers, “Feelz. The Way You Want.”

For more information and availability, please visit

About Cronos Group Inc.

Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos’ diverse international brand portfolio includes Spinach®, PEACE NATURALS® and Lord Jones®. For more information about Cronos and its brands, please visit: thecronosgroup.com.

Forward-looking Statements

This press release may contain information that may constitute “forward-looking information” or “forward-looking statements” within the meaning of applicable Canadian and U.S. securities laws and court decisions (collectively, “Forward-looking Statements”). All information contained herein that is not clearly historical in nature may constitute Forward-looking Statements. In some cases, Forward-looking Statements can be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “plan”, “anticipate”, “intend”, “potential”, “estimate”, “believe” or the negative of these terms, or other similar expressions intended to identify Forward-looking Statements. Some of the Forward-looking Statements contained in this press release include statements about anticipated product availability; anticipated product launches; the Spinach FEELZ™® product line; the advancement of cannabis research, technology and product development; and the Cronos brand portfolio. Forward-looking Statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks. Financial results, performance or achievements expressed or implied by those Forward-looking Statements are not guarantees of future performance. A discussion of some of the material risks applicable to the Company can be found in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, and the Company’s Quarterly Reports on Form 10-Q for the quarters ended March 31, 2023 and June 30, 2023, each of which has been filed on SEDAR and EDGAR and can be accessed at and /edgar, respectively. Any Forward-looking Statement included in this press release is made as of the date of this press release and, except as required by law, Cronos disclaims any obligation to update or revise any Forward-looking Statement. Readers are cautioned not to put undue reliance on any Forward-looking Statement.

For further information, please contact:

Media Relations Contact:

Emily Whalen

Communications

Tel: (416) 504-0004

Investor Relations Contact:

Shayne Laidlaw

Investor Relations

Tel: (416) 504-0004

Photos accompanying this announcement are available at:



EN
30/10/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Cronos Group Inc

 PRESS RELEASE

Cronos Group Reports 2025 First Quarter Results

Cronos Group Reports 2025 First Quarter Results Net revenue in Q1 2025 increased by 28% year-over-year, 33% year-over-year net revenue growth on a constant currency basis PEACE NATURALS® retained its position as the number one cannabis brand in Israel1 Industry-leading balance sheet with $838 million in total cash and cash equivalents and short-term investments TORONTO, May 08, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), today announced its 2025 first quarter business results. "2025 is shaping up to be a transformative yea...

 PRESS RELEASE

Cronos Group Inc. to Hold Virtual 2025 Annual Meeting of Shareholders

Cronos Group Inc. to Hold Virtual 2025 Annual Meeting of Shareholders TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2025 Annual Meeting of Shareholders on Friday, June 20, 2025, at 11:00 a.m. ET. Cronos will be conducting the meeting in a virtual-only format via live audio webcast. Registered shareholders and duly appointed proxyholders will have an equal opportunity to participate in the 2025 Annual Meeting online regardless of their geographic location, including a chance to ask questions and vote. Th...

 PRESS RELEASE

Cronos Group Inc. to Hold 2025 First Quarter Earnings Conference Call ...

Cronos Group Inc. to Hold 2025 First Quarter Earnings Conference Call on May 8, 2025 TORONTO, April 24, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2025 first quarter earnings conference call on Thursday, May 8, 2025 at 8:30 a.m. ET. Cronos’ senior management team will discuss the Company’s financial results and will be available for questions from the investment community after prepared remarks. To attend the conference call or webcast, participants should register online at . To avoid delays, we encourage participants ...

 PRESS RELEASE

Cronos Unveils New Spinach® 1.2g Vapes and SOURZ by Spinach® Gummies E...

Cronos Unveils New Spinach® 1.2g Vapes and SOURZ by Spinach® Gummies Enhanced with Rare Cannabinoids TORONTO, April 22, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc.’s (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) best-selling cannabis brand, Spinach®, is thrilled to introduce three all-new 1.2g vape products, each expertly crafted with premium THC and enhanced with rare cannabinoids for a uniquely elevated experience. Along with these innovative vape offerings, Cronos is also unveiling new SOURZ by Spinach® Fully Blasted flavors, infused with rare cannabinoids. The new lineup incl...

 PRESS RELEASE

Cronos Appoints Anna Shlimak as Chief Financial Officer

Cronos Appoints Anna Shlimak as Chief Financial Officer TORONTO, March 19, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced the appointment of Anna Shlimak as Chief Financial Officer, effective today. Ms. Shlimak, who previously served as Cronos’ Chief Strategy Officer, will succeed James Holm who is stepping down to pursue other opportunities and will remain with the Company through April 18, 2025 to ensure a seamless transition. Ms. Shlimak has been an integral part of Cronos...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch